Clinical Trial Update: Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on secondary prophylaxis in Non-Hodgkin Lymphoma and chemotherapy-induced thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Andres J. M. Ferreri | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED